REG - Hikma Pharmaceutical - Director/PDMR Shareholding

Hikma PharmaceuticalsAnnouncement

28/02/2020 12:30

RNS Number : 5272E
  
Hikma Pharmaceuticals Plc
  
28 February 2020
  
 

Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons discharging managerial responsibilities
Said Darwazah



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Said Darwazah




2


Reason for the notification




a)


Position/status


Executive Chairman 




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin.  The Executive Chairman is a director of and shareholder in Darhold Limited with an equity interest of 21.99%.




c)


Price(s) and volume(s)


Price(s): £0.00p
Volume(s): 1,000,000




d)


Aggregated information


Aggregated volume: 1,000,000
Price: £0.00p




e)


Date of the transaction


28 February 2020




f)


Place of the transaction


Amman



 Mazen Darwazah



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Mazen Darwazah




2


Reason for the notification




a)


Position/status


Executive Vice Chairman 




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin.  The Executive Vice Chairman is a director of and shareholder in Darhold Limited with an equity interest of 11.08%.




c)


Price(s) and volume(s)


Price(s): £0.00p
Volume(s): 1,000,000




d)


Aggregated information


Aggregated volume: 1,000,000
Price: £0.00p




e)


Date of the transaction


28 February 2020




f)


Place of the transaction


Amman



Mohammed 'Ali' Al-Husry



1


Details of the person discharging managerial responsibilities / person closely associated




a)


Name


Mohammed 'Ali' Al-Husry




2


Reason for the notification




a)


Position/status


Non-Executive Director




b)


Initial notification /Amendment


Initial notification




3


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


Hikma Pharmaceuticals PLC




b)


LEI


549300BNS685UXH4JI75




4


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted




a)


Description of the financial instrument, type of instrument and identification code


Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083




b)


Nature of the transaction
 


Release of a pledge by Darhold Limited over 1,000,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of Bank J. Safra Sarasin.  The Non-Executive Director is a director of and shareholder in Darhold Limited with an equity interest of 8.13%.




c)


Price(s) and volume(s)


Price(s): £0.00p
Volume(s): 1,000,000




d)


Aggregated information


Aggregated volume: 1,000,000
Price: £0.00p




e)


Date of the transaction


28 February 2020




f)


Place of the transaction


Amman



 
 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
  END
 
 
DSHBDGDDXDDDGGI